Immunotherapy is the ‘Next Era’ of Cancer Treatment and BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) is Taking Steps Forward in this Field
Multiple breakthroughs in the field of onco-immunology are expected over the next 20 years BriaCell Therapeutics Corp. is a frontrunner in this area, as it has already established proof of concept for its Bria-IMT solution for advanced breast cancer patients The company is also developing Bria-OTS, a personalized off-the-shelf solution, that will be much easier and less costly to manufacture than comparable personalized immunotherapies According to a report published in the British Society of Immunology, a new era has begun in the battle against cancer, as the development of immunotherapies for malignancies will take cancer treatments to a whole new…